Anixa Biosciences, Inc. (ANIX) is a publicly traded Healthcare sector company. As of July 13, 2026, ANIX trades at $3.06 with a market cap of $104.11M and a P/E ratio of -9.10. ANIX moved -0.33% today. Year to date, ANIX is -1.92%; over the trailing twelve months it is -2.55%. Its 52-week range spans $2.07 to $5.46. Analyst consensus is strong buy with an average price target of $10.33. Rallies surfaces ANIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ANIX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $3.06 |
| Market Cap | $104.11M |
| P/E Ratio | -9.10 |
| EPS | $-0.34 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.46 |
| 52-Week Low | $2.07 |
| Volume | 163.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-11.03M |
| Gross Margin | 0.00% |
3 analysts cover ANIX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.33.